Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02966132 · ClinicalTrials.gov registry record · NA

Interactive Mobile Doctor (iMD) for Asian Smokers

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
172
Enrollment target

NCT02966132: Completed NA study, sponsored by University of California, San Francisco.

NCT02966132 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 172 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02966132, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
172 participants
Enrollment target

Study Summary

The primary aim of the proposed study is to conduct a randomized controlled trial (RCT) to evaluate the efficacy of the Interactive Mobile Doctor (iMD) intervention targeting 150 Chinese-, Korean- or Vietnamese-speaking male patients who smoke daily and have a scheduled clinic visit at Asian Health Services primary care.

Primary Outcome

7-day point prevalent smoking abstinence biochemically verified by salivary cotinine

Interventions

  • BEHAVIORAL iMD
  • BEHAVIORAL NPA

Trial Details

FieldValue
Enrollment Target 172 participants
Start Date 2016-11
Est. Completion 2019-09
Phase NA

What the finished NCT02966132 record still lists

NCT02966132 is an interventional study that assigns participants to a tested intervention. The registered 172 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 2 interventions - of which iMD is the first listed.

NCT02966132 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02966132 about?

NCT02966132 is a clinical study titled "Interactive Mobile Doctor (iMD) for Asian Smokers". The primary aim of the proposed study is to conduct a randomized controlled trial (RCT) to evaluate the efficacy of the Interactive Mobile Doctor (iMD) intervention targeting 150 Chinese-, Korean- or Vietnamese-speaking male patients who smoke daily and have a scheduled clinic visit at Asian Health ...

What is the current status of trial NCT02966132?

This trial is currently completed. It is a NA study. The enrollment target is 172 participants. The study started on 2016-11. Estimated completion is 2019-09.

What interventions are being tested in trial NCT02966132?

The interventions under investigation include: iMD (BEHAVIORAL), NPA (BEHAVIORAL).

Who is sponsoring clinical trial NCT02966132?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02966132's enrollment target sits among peer trials

172 612th of 2000 higher than 1,389 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04801797 · 172 participants · Phase 2

    Venetoclax + Azacitidine vs. Induction Chemotherapy in AML

  • NCT04867317 · 172 participants · Phase 3

    Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)

  • NCT05357040 · 172 participants · Phase 2

    Antidepressant Effects of Nitrous Oxide

  • NCT05587517 · 172 participants · Phase 2

    A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02966132, the US trial registry maintained by the National Library of Medicine. NCT02966132 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.